The Changing Antifibrotic Landscape for the APP
The Changing Antifibrotic Landscape for the APP Kelsey Cramer DNP Antifibrotic therapy for Interstitial lung disease is shifting from a narrow, IPF- […]
APAPP Podcast 2025 Year in Review
What a year it has been for the APAPP Podcast! As 2025 draws to a close, we are thrilled to look back […]
APAPP Announces 3rd Annual National Conference
We are so excited to announce that the 3rd Annual APAPP National Conference will be held June 18-20, 2026, at the Red […]
Essential ILD Resources for APPs
The landscape of Interstitial Lung Disease (ILD) management is rapidly evolving, and with a promising new drug expected to enter the market […]